Clinical Trial Update: A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

BeOne Medicines reports a Phase 1 trial of BG-60366 in adults with EGFR-mutant non-small cell lung cancer. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BG-60366

Snippet

Sponsor: BeOne Medicines | Conditions: Non-Small Cell Lung Cancer, Lung Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING